Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiawei Liangxue Xiaofeng San
- Development stage
- Unknown
- Lead developer
- Sun Herbal
- Administration
- Oral
01
Overview
Jiawei Liangxue Xiaofeng San is a modified Traditional Chinese Medicine (TCM) herbal formula primarily utilized for the treatment of psoriasis vulgaris, specifically the "Blood-Heat" syndrome subtype. The formula is a supplementation of the classic Liangxue Xiaofeng San, designed to "cool the blood" and "eliminate wind" to alleviate skin inflammation, pruritus, and scaling. Clinical research, including trials conducted by the Hospital of Chengdu University of Traditional Chinese Medicine, has investigated its efficacy in reducing Psoriasis Area and Severity Index (PASI) scores and modulating inflammatory cytokine levels. As a multi-herb preparation, it is typically administered orally in powder or granule form.
- Brand names
- supplemented liang xue xiao feng powder
- Other names
- Supplemented Liang Xue Xiao Feng PowderJiawei Liangxue Xiaofeng Powder加味凉血消风散
02
Targets
STAT3 (Signal Transducer and Activator of Transcription 3)JAK2 (Janus kinase 2)SOCS3 (Suppressor of cytokine signaling 3)
Beyond the preview
Go deeper on Jiawei Liangxue Xiaofeng San.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jiawei Liangxue Xiaofeng San.